Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 296, Issue 5, 2009, Pages

  Kuboki, Satoshi ^a   Sakai, Nozomu ^a   Tschöp, Johannes ^a   Edwards, Michael J ^a   Lentsch, Alex B ^a,b   Caldwell, Charles C ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

T cell; Natural killer T cell; OT II; T cell receptor

Indexed keywords

CD1D ANTIGEN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; CD1D1 PROTEIN, MOUSE; IL2RA PROTEIN, MOUSE; INTERLEUKIN 2 RECEPTOR ALPHA; KLRB1C PROTEIN, MOUSE; LY ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; GAMMA,DELTA T LYMPHOCYTE; LIVER ISCHEMIA; MALE; MOUSE; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REPERFUSION INJURY; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; DISEASE MODEL; IMMUNOLOGY; LIVER; LIVER DISEASE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; METABOLISM; MOUSE MUTANT; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; T LYMPHOCYTE RECEPTOR GENE;

ANIMALS; ANTIGENS, CD1D; ANTIGENS, LY; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; GENES, T-CELL RECEPTOR DELTA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LIVER; LIVER DISEASES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; NEUTROPHIL INFILTRATION; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; REPERFUSION INJURY;

EID: 66149107042     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90464.2008     Document Type: Article

References (44)

1. Askenasy N, Kaminitz A, Yarkoni S. Mechanisms of T regulatory cell function. Autoimmun Rev 7: 370-375, 2008.
2. Bacon KB, Premack BA, Gardner P, Schall TJ. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269: 1727-1730, 1995.
3. Barone S, Okaya T, Rudich S, Petrovic S, Tenrani K, Wang Z, Zahedi K, Casero RA, Lentsch AB, Soleimani M. Distinct and sequential upregulation of genes regulating cell growth and cell cycle progression during hepatic ischemia-reperfusion injury. Am J Physiol Cell Physiol 289: C826-C835, 2005.
4. Caldwell CC, Okaya T, Martignoni A, Husted T, Schuster R, Lentsch AB. Divergent functions of CD4+ T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 289: G969-G976, 2005.
5. Carding SR, Egan PJ. Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol 2: 336-345, 2002.
6. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr. Role of tumor necrosis factor-alpha in the pathophysiologic alternations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 85: 1936-1943, 1990.
7. Derkow K, Loddenkemper C, Mintern J, Kruse N, Klugewitz K, Berg T, Wiedenmann B, Ploegh HL, Schott E. Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis. Hepatology 46: 1155-1165, 2007.
8. Emoto M, Miyamoto M, Emoto Y, Zerrahn J, Kaufmann SH. A critical role of T-cell receptor gamma/delta cells in antibacterial protection in mice early in life. Hepatology 33: 887-893, 2001.
9. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name? Nat Rev Immunol 4: 231-237, 2004.
10. Haas W, Pereira P, Tonegawa S. Gamma/delta cells. Annu Rev Immunol 11: 637-685, 1993.
11. Hammond KJ, Pellicci DG, Poulton LD, Naidenko OV, Scalzo AA, Baxter AG, Godfrey DI. CD1d-restricted NKT cells: an interstrain comparison. J Immunol 167: 1164-1173, 2001.
12. Hayday A, Tigelaar R. Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol 3: 233-242, 2003.
13. Hochegger K, Schätz T, Eller P, Tagwerker A, Heininger D, Mayer G, Rosenkranz AR. Role of alpha/beta and γ/δ T cells in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 293: F741-F747, 2007.
14. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 284: G15-G26, 2003.
15. Jaeschke H, Bautista AP, Spolarics Z, Spitzer JJ. Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radic Res Commun 15: 277-284, 1991.
16. Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol Gastrointest Liver Physiol 260: G355-G362, 1991.
17. Jaeschke H, Smith CW. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol 61: 647-653, 1997.
18. Jaeschke H, Smith CW, Clemens MG, Ganey PE, Roth RA. Mechanisms of inflammatory liver injury: adhesion molecules and cytotoxicity of neutrophils. Toxicol Appl Pharmacol 139: 213-226, 1996.
19. Kato A, Gabay C, Okaya T, Lentsch AB. Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion. Am J Pathol 161: 1797-1803, 2002.
20. Khandoga A, Hanschen M, Kessler JS, Krombach F. CD4+ T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets. Hepatology 43: 306-315, 2006.
21. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 23: 877-900, 2005.
22. Kuboki S, Shin T, Huber N, Eismann T, Galloway E, Schuster R, Blanchard J, Edwards MJ, Lentsch AB. Hepatocyte signaling through CXCR2 is detrimental to liver recovery after ischemia/reperfusion in mice. Hepatology 48: 1213-1223, 2008.
23. Kuniyasu Y, Takahashi T, Itoh M, Shimizu J, Toda G, Sakaguchi S. Naturally anergic and suppressive CD4+CD25+ T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol 12: 1145-1155, 2000.
24. Kurokawa T, Kobayashi H, Nonami T, Harada A, Nakao A, Sugiyama S, Ozawa T, Takagi H. Beneficial effects of cyclosporine on postischemic liver injury in rats. Transplantation 53: 308-311, 1992.
25. Lappas CM, Day YJ, Marshall MA, Engelhard VH, Linden J. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J Exp Med 203:2639-2648, 2006.
26. Leite-De-Moraes MC, Hameg A, Arnould A, Machavoine F, Koezuka Y, Schneider E, Herbelin A, Dy M. A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. J Immunol 163: 5871-5876, 1999.
27. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 32: 169-173, 2000.
28. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology 27:1172-1177, 1998.
29. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology 27: 1172-1177, 1998.
30. Loi P, Paulart F, Pajak B, Nagy N, Salmon I, Moser M, Goldman M, Flamand V. The fate of dendritic cells in a mouse model of liver ischemia/reperfusion injury. Transplant Proc 36: 1275-1279, 2004.
31. Mercer JC, Ragin MJ, August A. Natural killer T cells: rapid responders controlling immunity and disease. Int J Biochem Cell Biol 37: 1337-1343, 2005.
32. +) in kidney ischemia-reperfusion injury (Abstract). Transplantation 82: 1042-1043, 2006.
33. Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 59: 3128-3133, 1999.
34. Pennington DJ, Vermijlen D, Wise EL, Clarke SL, Tigelaar RE, Hayday AC. The integration of conventional and unconventional T cells that characterizes cell-mediated responses. Adv Immunol 87: 27-59, 2005.
35. Sakr MF, Abdel-Aal AN. Protective effect of cyclosporine A (CyA) against the hepatic injury associated with ischemia and reperfusion. Int Surg 81: 180-183, 1996.
36. Savransky V, Molls RR, Burne-Taney M, Chien CC, Racusen L, Rabb H. Role of the T-cell receptor in kidney ischemia-reperfusion injury. Kidney Int 69: 233-238, 2006.
37. Shimamura K, Kawamura H, Nagura T, Kato T, Naito T, Kameyama H, Hatakeyama K, Abo T. Association of NKT cells and granulocytes with liver injury after reperfusion of the portal vein. Cell Immunol 234: 31-38, 2005.
38. + immunoregulatory cells is antigen nonspecific. J Immunol 164: 183-190, 2000.
39. Tschöp J, Martignoni A, Goetzman HS, Choi LG, Wang Q, Noel JG, Ogle CK, Pritts TA, Johannigman JA, Lentsch AB, Caldwell CC. Gammadelta T cells mitigate the organ injury and mortality of sepsis. J Leukoc Biol 83: 581-588, 2008.
40. Tsung A, Zheng N, Jeyabalan G, Izuishi K, Klune JR, Geller DA, Lotze MT, Lu L, Billiar TR. Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury. J Leukoc Biol 81: 119-128, 2007.
41. Vivier E, Toselo E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 9: 503-510, 2008.
42. Wanner GA, Ertel W, Müller P, Höfer Y, Leiderer R, Menger MD, Messmer K. Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock 5: 34-40, 1996.
43. Zhang M, Alicot EM, Chiu I, Li J, Verna N, Vorup-Jensen T, Kessler B, Shimaoka M, Chan R, Friend D, Mahmood U, Weissleder R, Moore FD, Carroll MC. Identification of the target self-antigens in reperfusion injury. J Exp Med 203: 141-152, 2006.
44. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, Engelhardt JF. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 100: 279-289, 1997.